NCT05945095

Brief Summary

The study will be conducted on mothers who had planned cesarean section.After the birth, the information about the surgery in the personal information form will be completed. Then, mothers in the control group will be given standard postpartum care. The mothers in the experimental group, on the other hand, will chew sugar-free gum for at least 15 minutes, starting from the second hour after the surgery. The gum chewing process will be repeated every two hours. Mothers will be mobilized at the 8th sat after the birthday. Pain levels of mothers in both groups will be evaluated every two hours after delivery. In addition, the amount of analgesic use will be compared and comments will be made on the level of pain. The sleep quality of the postpartum women will be questioned the day after the cesarean section.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 27, 2023

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

April 5, 2023

Completed
3 months until next milestone

First Posted

Study publicly available on registry

July 14, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 27, 2023

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 20, 2024

Completed
Last Updated

July 14, 2023

Status Verified

July 1, 2023

Enrollment Period

9 months

First QC Date

April 5, 2023

Last Update Submit

July 6, 2023

Conditions

Keywords

General anesthesia,Sleep QualityChewing Gum, Pain,Cesarean section,

Outcome Measures

Primary Outcomes (1)

  • Visual Analogue Scale (VAS)

    VAS is used to measure perceived pain. VAS is a 10cm line with anchor statements on lower end (no pain) and on upper end (extreme pain). The mother is asked to mark their current pain level on the line

    "change" is being assessed. up to 10-12 hours after cesarean section

Secondary Outcomes (1)

  • Richard-Campbell Sleep Scale (RCUI)

    in the morning the day after the cesarean section

Study Arms (2)

Experimental group

EXPERIMENTAL

Gum chewing group

Other: Gum chewing group

Control group

NO INTERVENTION

Routine care

Interventions

The mothers in the experimental group, on the other hand, will chew sugar-free gum for at least 15 minutes, starting from the second hour after the surgery.

Experimental group

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Be eighteen years of age or older,
  • Having a planned cesarean section,
  • To receive general anesthesia in the surgery,
  • No history of chronic constipation and diarrhea,
  • At least primary school graduate
  • Communication is not a problem.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Artvin State Hospital

Artvin, 08000, Turkey (Türkiye)

RECRUITING

Related Publications (1)

  • Pereira Gomes Morais E, Riera R, Porfirio GJ, Macedo CR, Sarmento Vasconcelos V, de Souza Pedrosa A, Torloni MR. Chewing gum for enhancing early recovery of bowel function after caesarean section. Cochrane Database Syst Rev. 2016 Oct 17;10(10):CD011562. doi: 10.1002/14651858.CD011562.pub2.

MeSH Terms

Conditions

Sleep Initiation and Maintenance DisordersPain

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Dilek KALOĞLU BİNİCİ, PhD

    Artvin Coruh University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Dilek KALOĞLU BİNİCİ, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: The sample size in similar studies was examined and it was determined that at least 30 mothers should be included in the experimental and control groups. Assignment of pregnant women to the experimental and control groups will be made using a simple random numbers table.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator (PhD Research Nurse)

Study Record Dates

First Submitted

April 5, 2023

First Posted

July 14, 2023

Study Start

March 27, 2023

Primary Completion

December 27, 2023

Study Completion

May 20, 2024

Last Updated

July 14, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations